Merit Medical Reports Strong Q4 & FY2025 Results, Issues Positive FY2026 Guidance

summarizeSummary

Merit Medical Systems announced strong Q4 and full year 2025 financial results, including significant EPS growth, and provided positive guidance for fiscal year 2026.

check_boxKey Events

• Strong Q4 2025 Financial Performance

  Reported revenue increased 11% to $393.9 million, and GAAP EPS rose 37% to $0.63 for the fourth quarter ended December 31, 2025.

• Solid Full Year 2025 Results

  Full year revenue grew 12% to $1.516 billion, with non-GAAP EPS increasing 11% to $3.83 for the fiscal year ended December 31, 2025.

• Positive Fiscal Year 2026 Guidance

  The company projects total revenue of $1.610 billion to $1.630 billion (6-8% growth) and non-GAAP EPS of $4.01 to $4.15 (5-8% growth) for fiscal year 2026.

• Improved Profitability and Free Cash Flow

  Non-GAAP operating margin improved to 21.0% in Q4 2025, and free cash flow generation for FY2025 was $215.7 million, representing a 16% increase year-over-year.

auto_awesomeAnalysis

Merit Medical Systems delivered robust financial results for both the fourth quarter and full fiscal year 2025, exceeding prior year performance across key metrics like revenue, EPS, and operating margins. The significant 37% increase in GAAP EPS for Q4 2025 highlights strong operational execution. Furthermore, the positive guidance for fiscal year 2026, projecting continued revenue and EPS growth, indicates management's confidence in sustained performance and strategic initiatives. This comprehensive update provides investors with a clear picture of the company's strong financial health and positive outlook, building on the preliminary revenue growth announced earlier.